{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:20Z","timestamp":1788355340909,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.trim.2023.101958","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:41:48Z","timestamp":1699501308000},"page":"101958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies"],"prefix":"10.1016","volume":"81","author":[{"given":"Tareq","family":"Hanouneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Mary","family":"Attieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Craver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Jebrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elrefaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambi","family":"Jarmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.trim.2023.101958_bb0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/j.ajkd.2019.01.031","article-title":"Management of kidney transplant recipients by general nephrologists: core curriculum 2019","volume":"73","author":"Voora","year":"2019","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.trim.2023.101958_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.TP.0000136263.46262.0D","article-title":"ABO-incompatible kidney transplantation","volume":"78","author":"Stegall","year":"2004","journal-title":"Transplantation."},{"issue":"3","key":"10.1016\/j.trim.2023.101958_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5500\/wjt.v8.i3.52","article-title":"Kidney exchange transplantation current status, an update and future perspectives","volume":"8","author":"Kute","year":"2018","journal-title":"World J. Transplant."},{"issue":"12","key":"10.1016\/j.trim.2023.101958_bb0020","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/01.tp.0000250906.66728.8d","article-title":"A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations","volume":"82","author":"de Klerk","year":"2006","journal-title":"Transplantation."},{"issue":"12","key":"10.1016\/j.trim.2023.101958_bb0025","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1111\/ajt.13409","article-title":"First report on the OPTN national variance: allocation of A2 \/A2 B deceased donor kidneys to blood group B increases minority transplantation","volume":"15","author":"Williams","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2023.101958_bb0030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0000000000000933","article-title":"Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review and meta-analysis","volume":"100","author":"Lo","year":"2016","journal-title":"Transplantation."},{"issue":"4","key":"10.1016\/j.trim.2023.101958_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MOT.0000000000000672","article-title":"Kidney transplantation across minor ABO incompatibility: the use of A2 to B transplants","volume":"24","author":"Gilbert","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.trim.2023.101958_bb0040","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1097\/01.tp.0000543283.85109.de","article-title":"A2 to b renal transplantation: one center\u2019s experience and the implications for decreasing wait times and reducing racial disparities in organ allocation","volume":"102","author":"Shapiro","year":"2018","journal-title":"Transplantation."},{"issue":"10","key":"10.1016\/j.trim.2023.101958_bb0045","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.transproceed.2018.06.034","article-title":"Repeat A2 into B kidney transplantation after failed prior A2 into B transplant: a case report","volume":"50","author":"Tatapudi","year":"2018","journal-title":"Transplant. Proc."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2023.101958_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/nep.12777","article-title":"Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation","volume":"21","author":"Morozumi","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.trim.2023.101958_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101778","article-title":"Basiliximab is associated with a lower incidence of De novo donor-specific HLA antibodies in kidney transplant recipients: a single-center experience","volume":"77","author":"Jarmi","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2023.101958_bb0060","author":"OPTN"},{"issue":"3","key":"10.1016\/j.trim.2023.101958_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1600-6143.2001.001003296.x","article-title":"Transplantation of ABO group A2 kidneys from living donors into group O and B recipients","volume":"1","author":"Sorensen","year":"2001","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2023.101958_bb0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ctr.12724","article-title":"A2 incompatible kidney transplantation does not adversely affect graft or patient survival","volume":"30","author":"Forbes","year":"2016","journal-title":"Clin. Transpl."},{"issue":"8","key":"10.1016\/j.trim.2023.101958_bb0075","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: a meta-analysis","volume":"13","author":"de Weerd","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"24","key":"10.1016\/j.trim.2023.101958_bb0080","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation","volume":"63","author":"Chapman","year":"2003","journal-title":"Drugs."},{"issue":"2\u20133","key":"10.1016\/j.trim.2023.101958_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trim.2012.08.006","article-title":"Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review","volume":"27","author":"Zhang","year":"2012","journal-title":"Transpl. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2023.101958_bb0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.14740\/jocmr4369","article-title":"The impact of different induction immunosuppressive therapy on long-term kidney transplant function when measured by Iothalamate clearance","volume":"12","author":"Jarmi","year":"2020","journal-title":"J. Clin. Med. Res."},{"issue":"2","key":"10.1016\/j.trim.2023.101958_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0897190019850934","article-title":"Comparison of Alemtuzumab versus Basiliximab induction therapy in elderly kidney transplant recipients: a single-center experience","volume":"34","author":"Yakubu","year":"2021","journal-title":"J. Pharm. Pract."},{"issue":"1","key":"10.1016\/j.trim.2023.101958_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/TP.0b013e31818c6db0","article-title":"Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation","volume":"87","author":"Pascual","year":"2009","journal-title":"Transplantation."},{"issue":"4","key":"10.1016\/j.trim.2023.101958_bb0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jamcollsurg.2018.12.023","article-title":"A2 to B kidney transplantation in the post-kidney allocation system era: a 3-year experience with anti-a titers, outcomes, and cost","volume":"228","author":"Shaffer","year":"2019","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"10.1016\/j.trim.2023.101958_bb0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-specific antibodies in kidney transplant recipients","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101958_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/849835","article-title":"Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation","volume":"2013","author":"Lionaki","year":"2013","journal-title":"Clin. Dev. Immunol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:06:02Z","timestamp":1760810762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"alternative-id":["S0966327423001752"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101958","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101958"}}